Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Neukio Bio of Shanghai Raises $40 Million for Universal CAR-T Therapies

Lupeng Pharma Closes $35 Million Pre-B Funding for Novel Drugs

Kumquat Announces $2 Billion Deal to Develop Small Molecule IO Drugs with Lilly

Bota Bio Adds $100 Million to B Round for Synthetic Biotech Manufacturing

Zion Pharma Raises $40 Million to Develop Therapies for Brain Metastases

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021